Diseases of the Colon & Rectum · 2015 · 108 citations · 36 references
MedicineOncologySurgeryGeriatric AssessmentSurgical OncologySurvival AnalysisColorectal CancerGeriatric OncologyNeoadjuvant ChemotherapyNeoadjuvant TherapyPrognostic AssessmentSurvival OutcomesColorectal Cancer Neoadjuvant TherapyDisease-free Survival AnalysisNeoadjuvant ChemoradiationNeoadjuvant ChemoradiotherapyPostoperative MortalityQuality-adjusted Life Year ModelingRectal Cancer Neoadjuvant TherapyRectal Cancer Surgery
BACKGROUND: In elderly and comorbid patients with rectal cancer, radical surgery is associated with significant perioperative mortality. Data suggest that a watch-and-wait approach where a complete clinical response is obtained after neoadjuvant chemoradiotherapy might be oncologically safe. OBJECTIVE: This study aimed to determine whether patient age and comorbidity should influence surgeon and patient decision making where a complete clinical response is obtained. DESIGN: Decision-analytic modeling consisting of a decision tree and Markov chain simulation was used. Modeled outcome parameters were elicited both from comprehensive literature review and from a national patient outcomes database. SETTINGS: Outcomes for 3 patient cohorts treated with neoadjuvant therapy were modeled after either surgery or watch and wait. PATIENTS: Patients included 60-year-old and 80-year-old men with mild comorbidities (Charlson score <3) and 80-year-old men with significant comorbidities (Charlson score >3). MAIN OUTCOME MEASURES: Absolute survival, disease-free survival, and quality-adjusted life years were measured. RESULTS: The model found that absolute survival was similar in 60-year-old patients but was significantly improved in fit and comorbid 80-year-old patients at 1 year after treatment where watch and wait was implemented instead of radical surgery, with a survival advantage of 10.1% (95% CI, 7.9-12.6) and 13.5% (95% CI, 10.2-16.9). At all of the other time points, absolute survival was equivalent for both techniques. There were no short- or long-term differences among any patient groups managed either by radical surgery or watch and wait in terms of either disease-free survival or quality-adjusted life years. LIMITATIONS: Oncologic data for the watch-and-wait approach used for this study is derived from only a small number of studies pertaining to a highly selected group of patients. The 90-day postoperative mortality rate derived from the United Kingdom population-based study might be lower in other countries or individual institutions. CONCLUSIONS: This study suggests competing effects of oncologic and surgical risk when using watch-and-wait management and that elderly and comorbid patients have the most to gain from this approach.
36
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Rolf Sauer, Heinz Becker, Werner Hohenberger et al. · New England Journal of Medicine · 2004 · 6.1K citations
Markov Models in Medical Decision Making
Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations